Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration

JAMA Network Open(2021)10.1001/jamanetworkopen.2021.36662Source: DataRank Database

Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration is a research paper published in JAMA Network Open (2021). On theSindex it has a DataRank of 0.561. It has been cited 41 times.

N/A

0.561DataRank · unranked

Scored on demand from live citation data

Open Access41 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 4.11)OA: goldTopics (78)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.561

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (7)

Kristi M. Swanson ORCID,Jiani Zhou ORCID,Anupam B. Jena ORCID,Joseph S. Ross ORCID,Nilay D. Shah ORCID

Live enrichment

PubMed:34851398 PMC:PMC8637256 OpenAlex:https://openalex.org/W3215879321

NCATS NIH HHS

Grant: UL1 TR001863

National Institutes of Health

Grant: 2P01AG005842-04

FINANCIAL STATUS--RETIREMENT SAVING PROGRAMS

National Institutes of Health

Grant: 1DP5OD017897-01

Physician Determinants of Health Care Spending, Quality, and Patient Outcomes

National Institutes of Health

Grant: 5R01HL144644-02

Leveraging Physician Networks to Improve Care and Outcomes for Low-Income Populations

National Institutes of Health

Grant: 1R56HL130496-01A1

Diffusion of Clinical Evidence into Practice: Physician Networks, Delivery Organizations, and Markets

National Institutes of Health

Grant: 1R01HL131535-01

Shared decision making for stroke prevention in atrial fibrillation (SDM4Afib)

National Institutes of Health

Grant: 1R01HS025402-01

Gastrointestinal Safety of Antithrombotic Drug Regimens

National Institutes of Health

Grant: 1R01HS022882-01

Understanding hospital readmission rates: patient, hospital and community effects

National Institutes of Health

Grant: 5R01HS025164-04

Medical reversals: De-implementing ineffective and unsafe treatments

National Institutes of Health

Grant: 5R03HS025517-02

The ICAN Discussion Aid to Optimize Treatment for People Living with Multiple Chronic Conditions

FWCI

4.11

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786698/sankar_2021_oi_211037_1637599176.13838.pdf

publisherhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2786698/sankar_2021_oi_211037_1637599176.13838.pdf

journalhttps://doi.org/10.1001/jamanetworkopen.2021.36662

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34851398

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8637256

Fields of Study

Pharmacovigilance and Adverse Drug ReactionsAntibiotic Use and ResistancePharmaceutical Quality and Counterfeiting03 medical and health sciences0302 clinical medicineAgedAged, 80 and overAmbulatory CareAnti-Bacterial AgentsBronchitisCross-Sectional StudiesDrug LabelingDrug PrescriptionsFemaleFluoroquinolonesHealth Plan ImplementationHumansInterrupted Time Series AnalysisMaleMedicareMiddle AgedPractice Patterns, Physicians'SinusitisUnited StatesUnited States Food and Drug AdministrationUrinary Tract Infections

MeSH Terms

AgedAged, 80 and overAmbulatory CareAnti-Bacterial AgentsBronchitisCross-Sectional StudiesDrug LabelingFemaleMedicareHealth Plan ImplementationHumansMaleMiddle AgedPractice Patterns, Physicians'Drug PrescriptionsSinusitisUnited StatesUnited States Food and Drug AdministrationUrinary Tract InfectionsFluoroquinolonesInterrupted Time Series Analysis

Keywords

Food and drug administrationAdministration (probate law)DrugBlack boxMedicineEnvironmental healthBusinessPharmacologyPolitical scienceComputer scienceAged, 80 and overMaleUnited States Food and Drug AdministrationHealth Plan ImplementationInterrupted Time Series AnalysisMiddle AgedMedicareDrug PrescriptionsUnited StatesAnti-Bacterial AgentsCross-Sectional StudiesAmbulatory CareHumansFemalePractice Patterns, Physicians'SinusitisBronchitisOriginal InvestigationAgedDrug LabelingFluoroquinolones

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being